4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0000899243-16-018345
EVP, QA & Regulatory Affairs sold 21,244 shares at an average $12.89 ($273,774)
- EVP, QA & Regulatory Affairs acquired 19,817 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-18 | Option exercise | +8,210 | $10.48 | $86,041 | 39,713 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-18 | Option exercise | +6,000 | $11.41 | $68,460 | 45,713 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-18 | Sale | −15,637 | $12.83 | $200,649 | 30,076 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-19 | Option exercise | +5,607 | $10.48 | $58,761 | 35,683 | D |
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-19 | Sale | −5,607 | $13.04 | $73,125 | 30,076 | D |
| Derivatives | |||||||
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-18 | Option exercise · Employee Stock Option (right to buy) | −6,000 | 9,000 | D | ||
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-18 | Option exercise · Employee Stock Option (right to buy) | −8,210 | 11,790 | D | ||
| Gerst Diane G. EVP, QA & Regulatory Affairs | 2016-04-19 | Option exercise · Employee Stock Option (right to buy) | −5,607 | 6,183 | D | ||
| Open-market sales · 21,244 sh · avg $12.89 · $273,774 | |||||||
Loading xslF345X03/doc4.xml…